Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease

Background Patients with essential thrombocythemia (ET) and coronary artery disease (CAD) have increased risk of thromboembolic complications. In addition, a reduced antiplatelet effect of aspirin has been demonstrated in both patient groups. As ET is a platelet disorder, platelets may be more impor...

Full description

Bibliographic Details
Main Authors: Oliver Buchhave Pedersen, Anne-Mette Hvas, Hans Beier Ommen, Steen Dalby Kristensen, Erik Lerkevang Grove
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2021-07-01
Series:TH Open
Subjects:
aspirin
essential thrombocythemia
platelet aggregation
thromboxane b2
platelet activation
platelet function test
coronary artery disease
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731309

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731309

Similar Items